Clinical Trials Directory

Trials / Completed

CompletedNCT05593744

Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma

Study on the Correlation Between Thyroid Dysfunction Induced by Anti PD-1 Therapy and Prognosis in Patients With Advanced Carcinoma

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, we monitored patients with advanced malignant tumors who received anti-PD-1 therapy to observe the characteristic of anti-PD-1 therapy-induced thyroid dysfunction and its correlation with prognosis.

Conditions

Interventions

TypeNameDescription
OTHERno interventionThis is an observational study so not involved intervention

Timeline

Start date
2020-08-17
Primary completion
2022-03-30
Completion
2022-03-30
First posted
2022-10-25
Last updated
2022-10-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05593744. Inclusion in this directory is not an endorsement.

Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma (NCT05593744) · Clinical Trials Directory